NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced two major steps to enhance shareholder value. First, the Board of Directors has agreed to acquire its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback